Preferred Stock - Convertible Exchangeable Series 1 $2.4375 Dark or Defunct
Pink No Information
Contact Info
  • 300 Elliott Avenue West
  • Suite 530
  • Seattle, WA 98119

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Apr 02, 2012
Audited Financials Audited
Latest Report Sep 30, 2011 10-Q
CIK 0000755806
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: WA, USA
Year of Inc. 1984
Employees Not Available
Company Officers/Contacts
Michael A. Jackson Interim CFO
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm
Ernst & Young LLP
5 Times Square
New York, NY, 10036-6530
United States
Securities Counsel
Perkins Coie, LLP
1620 - 26th Street
South Tower
Santa Monica, CA, 90404-4013
United States
Investor Relations Firm
Argot Partners
200 Park Avenue South
Suite 1515
New York, NY, 10003
United States
Company History
  • Formerly=NeoRx Corp. until 6-06
PARDP Security Details Other Company Securities
Share Structure
Market Value1 $47,261 a/o Oct 23, 2017
Authorized Shares 1,120,000 a/o Dec 31, 2011
Outstanding Shares 78,768 a/o Dec 31, 2011
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders of Record Not Available
Short Selling Data
Short Interest 9,373 (0%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security